Monday, December 23, 2024
Google search engine
HomeUncategorizedShattuck Labs’ stock craters as biotech scraps main product candidate after failed...

Shattuck Labs’ stock craters as biotech scraps main product candidate after failed trial

The stock hit a low of $1.37 earlier in the session, matching its record closing low that was set in October 2023.

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments